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o the Editor:
e read with interest the recent study on care coordination for
irrhotic patients by Morando et al., with an accompanying edito-
ial [1,2]. Firstly, we would like to congratulate the Padova group
r focusing their research interest on this important topic and
atient population.
We must, however, correct the statement of the editorialists
at this study represents the ‘‘ﬁrst prospective trial in the
irrhosis population’’ [2]. We highlight the publication of our
wn randomized controlled trial of coordinated cirrhosis care,
hich preceded the publication of the Padova study in the
terature [3].
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e did not detect any improvement in either hospitalization
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A major limitation of the Padova study is its lack of a blinded
nd completely randomized group allocation procedure, which
as instead based on retrospective matching of known
onfounders. As a consequence, it remains possible that the
eneﬁcial effects seen were not related to the new care model,
improved. Authors propose increased contacts with specialist
physicians as explanation for improved outcomes in the coordi-
nated care group. However, no analysis was performed to support
the claims for associations between outcomes and greater spe-
cialist visit numbers being associated with reduced risk of
mortality.
In relation tomortality, the authors chose not to discuss the dis-
tribution of events throughout the study. A careful examination of
the Kaplan Meier curves does however reveal some important
details. Firstly, there was an increased risk of death for standard
care patients during the ﬁrst 3 months of the trial relative to
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expecteddeaths for patients at this level ofMELD/Child Pugh score.
There was also an increased risk of mortality in the intervention
group compared to the standard care group in the second half of
the trial. Additionally, themuch lower risk for the coordinated care
group in the ﬁrst 3 months followed by a higher risk indicates that
beneﬁts of the program were mostly achieved early on and were
therefore probably not strongly related to the total number of
visits/time spent with clinicians. Likewise, the unexpectedly high
death rate in the standard care group suggests either that the
standard care program provided was below the average standard
careprogram, that thepatients in this groupwere sicker in respects
to factors other than their MELD score, or perhaps that the group
allocation procedure lead standard care patients to amore delayed
treatment following discharge.
With respect to the data on readmissions, knowledge of the
unadjusted effects of the program, in addition to the adjusted
effects, would have been useful to determine if confounding
was present. The adjusted nature of the analysis, rather than a
simple unadjusted comparison, perhaps reﬂects the observa-
tional nature of the study since an RCT automatically eliminates
confounding from both known and unknown risk factors and
does not therefore require statistical adjustment. We were also
intrigued that although the analysis suggests an important effect
of the intervention, a surprising additional result was that several
known risk factors for readmission, including age and MELD,
were not independent predictors beyond the group allocation.
This suggests that the group allocation effect on readmission
was strongly associated with these variables. We highlight the
possibility that good coordinated care for sick patients may
generate an increase in emergency readmissions in the short
term, via improved access to care. This was an interesting
ﬁnding in our study [3] and has also been noted by other
investigators [4].
For new care models to be adopted in cirrhosis the evidence
base must be of the highest order, as it has been the case for other
diseases such as heart failure [5]. In the absence of high quality
evidence, the signiﬁcant upfront costs associated with re-orga-
nizing care along new models, are unlikely to be funded by
current health care systems. Although we believe instinctively
these models will w
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To the Editor:
We would like to thank A.J. Wigg et al. for their interest in our
study about a new model of care coordination by consultant
hepatologists in outpatients with cirrhosis and ascites [1]. We
regret that the Editorialists have not considered their publica-
tion but, such is life! Moreover, it should be recognized that
the appearance of the two manuscripts on PubMed were very
close each to one other. In their letter [2] A.J. Wigg et al. high-
lighted once again that our study was not randomized and sug-
gested that the differences in outcomes of the two groups of
our work were not linked to the process of management as
outpatients, but to confounding factors that were not well bal-
anced between the two groups. The circumstance that our
study was not randomized has been already stressed by our-
selves and by the editorialists. We also set out to explain the
reasons why we decided to perform this type of study. As far
as the enrollment and the matching process are concerned,
as we stated in the paper, patients were enrolled consecutively
on discharge from hospitalization due to acute decompensation
of cirrhosis, and subjected to matching for a large number of
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